
Weiping Zhu
Examiner (ID: 5897, Phone: (571)272-6725 , Office: P/1733 )
| Most Active Art Unit | 1733 |
| Art Unit(s) | 1742, 1793, 1734, 1733 |
| Total Applications | 1183 |
| Issued Applications | 606 |
| Pending Applications | 6 |
| Abandoned Applications | 574 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18771226
[patent_doc_number] => 20230366042
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-16
[patent_title] => DNA NANODEVICE HINGE BIOSENSORS AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/029770
[patent_app_country] => US
[patent_app_date] => 2021-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19767
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18029770
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/029770 | DNA NANODEVICE HINGE BIOSENSORS AND METHODS OF USE THEREOF | Sep 30, 2021 | Pending |
Array
(
[id] => 17735099
[patent_doc_number] => 20220220558
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-14
[patent_title] => METHODS AND SYSTEMS FOR PROGNOSIS OF A PATIENT'S RESPONSE TO TREATMENT OF ANDROGENETIC SKIN DISORDERS
[patent_app_type] => utility
[patent_app_number] => 17/491134
[patent_app_country] => US
[patent_app_date] => 2021-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8286
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -38
[patent_words_short_claim] => 198
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17491134
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/491134 | METHODS AND SYSTEMS FOR PROGNOSIS OF A PATIENT'S RESPONSE TO TREATMENT OF ANDROGENETIC SKIN DISORDERS | Sep 29, 2021 | Abandoned |
Array
(
[id] => 17612006
[patent_doc_number] => 20220154285
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-19
[patent_title] => ANALYSIS OF METHYLATED DNA COMPRISING METHYLATION-SENSITIVE OR METHYLATION-DEPENDENT RESTRICTIONS
[patent_app_type] => utility
[patent_app_number] => 17/489687
[patent_app_country] => US
[patent_app_date] => 2021-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 47736
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17489687
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/489687 | ANALYSIS OF METHYLATED DNA COMPRISING METHYLATION-SENSITIVE OR METHYLATION-DEPENDENT RESTRICTIONS | Sep 28, 2021 | Pending |
Array
(
[id] => 17627655
[patent_doc_number] => 20220162670
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-26
[patent_title] => METHODS AND SYSTEMS TO IMPROVE THE SIGNAL TO NOISE RATIO OF DNA METHYLATION PARTITIONING ASSAYS
[patent_app_type] => utility
[patent_app_number] => 17/489677
[patent_app_country] => US
[patent_app_date] => 2021-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 56642
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17489677
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/489677 | METHODS AND SYSTEMS TO IMPROVE THE SIGNAL TO NOISE RATIO OF DNA METHYLATION PARTITIONING ASSAYS | Sep 28, 2021 | Pending |
Array
(
[id] => 20302667
[patent_doc_number] => 12448646
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-10-21
[patent_title] => SSB method
[patent_app_type] => utility
[patent_app_number] => 17/481374
[patent_app_country] => US
[patent_app_date] => 2021-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 30285
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 159
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17481374
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/481374 | SSB method | Sep 21, 2021 | Issued |
Array
(
[id] => 17344054
[patent_doc_number] => 20220010385
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-13
[patent_title] => METHODS FOR DETECTING INACTIVATION OF THE HOMOLOGOUS RECOMBINATION PATHWAY (BRCA1/2) IN HUMAN TUMORS
[patent_app_type] => utility
[patent_app_number] => 17/474334
[patent_app_country] => US
[patent_app_date] => 2021-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28514
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17474334
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/474334 | METHODS FOR DETECTING INACTIVATION OF THE HOMOLOGOUS RECOMBINATION PATHWAY (BRCA1/2) IN HUMAN TUMORS | Sep 13, 2021 | Pending |
Array
(
[id] => 17520794
[patent_doc_number] => 20220106643
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-07
[patent_title] => METHODS FOR DETERMINING THE QUALITY OF AN EMBRYO
[patent_app_type] => utility
[patent_app_number] => 17/472848
[patent_app_country] => US
[patent_app_date] => 2021-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7495
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -2
[patent_words_short_claim] => 92
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17472848
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/472848 | METHODS FOR DETERMINING THE QUALITY OF AN EMBRYO | Sep 12, 2021 | Abandoned |
Array
(
[id] => 19091191
[patent_doc_number] => 11952623
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-04-09
[patent_title] => Simultaneous determination of aneuploidy and fetal fraction
[patent_app_type] => utility
[patent_app_number] => 17/465163
[patent_app_country] => US
[patent_app_date] => 2021-09-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 32479
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 397
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17465163
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/465163 | Simultaneous determination of aneuploidy and fetal fraction | Sep 1, 2021 | Issued |
Array
(
[id] => 17563533
[patent_doc_number] => 20220127682
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-28
[patent_title] => SELECTION AND TREATMENT OF CANCER WITH COMBINATION THERAPIES
[patent_app_type] => utility
[patent_app_number] => 17/459477
[patent_app_country] => US
[patent_app_date] => 2021-08-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 39124
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -34
[patent_words_short_claim] => 111
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17459477
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/459477 | SELECTION AND TREATMENT OF CANCER WITH COMBINATION THERAPIES | Aug 26, 2021 | Abandoned |
Array
(
[id] => 18844998
[patent_doc_number] => 20230407402
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-21
[patent_title] => PREDICTION OF A RESPONSE OF A PROSTATE CANCER SUBJECT TO THERAPY OR PERSONALIZATION OF THERAPY OF A PROSTATE CANCER SUBJECT
[patent_app_type] => utility
[patent_app_number] => 18/023598
[patent_app_country] => US
[patent_app_date] => 2021-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31620
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 159
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18023598
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/023598 | PREDICTION OF A RESPONSE OF A PROSTATE CANCER SUBJECT TO THERAPY OR PERSONALIZATION OF THERAPY OF A PROSTATE CANCER SUBJECT | Aug 23, 2021 | Pending |
Array
(
[id] => 17258952
[patent_doc_number] => 20210371937
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-02
[patent_title] => METHOD FOR IDENTIFYING HIGH-RISK AML PATIENTS
[patent_app_type] => utility
[patent_app_number] => 17/395244
[patent_app_country] => US
[patent_app_date] => 2021-08-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22685
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17395244
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/395244 | METHOD FOR IDENTIFYING HIGH-RISK AML PATIENTS | Aug 4, 2021 | Abandoned |
Array
(
[id] => 17482703
[patent_doc_number] => 20220090207
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-24
[patent_title] => DETECTING CANCER, CANCER TISSUE OF ORIGIN, AND/OR A CANCER CELL TYPE
[patent_app_type] => utility
[patent_app_number] => 17/384251
[patent_app_country] => US
[patent_app_date] => 2021-07-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 48080
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17384251
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/384251 | DETECTING CANCER, CANCER TISSUE OF ORIGIN, AND/OR A CANCER CELL TYPE | Jul 22, 2021 | Pending |
Array
(
[id] => 17357176
[patent_doc_number] => 20220017972
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-20
[patent_title] => METHODS FOR DETECTING INACTIVATION OF THE HOMOLOGOUS RECOMBINATION PATHWAY (BRCA1/2) IN HUMAN TUMORS
[patent_app_type] => utility
[patent_app_number] => 17/381272
[patent_app_country] => US
[patent_app_date] => 2021-07-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10288
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 83
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17381272
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/381272 | METHODS FOR DETECTING INACTIVATION OF THE HOMOLOGOUS RECOMBINATION PATHWAY (BRCA1/2) IN HUMAN TUMORS | Jul 20, 2021 | Abandoned |
Array
(
[id] => 18658103
[patent_doc_number] => 20230304091
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-28
[patent_title] => MINIMALLY INVASIVE KIT FOR DIAGNOSING SKIN CONDITION, COMPRISING MICRONEEDLE PATCH
[patent_app_type] => utility
[patent_app_number] => 18/020846
[patent_app_country] => US
[patent_app_date] => 2021-07-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26639
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 183
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18020846
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/020846 | MINIMALLY INVASIVE KIT FOR DIAGNOSING SKIN CONDITION, COMPRISING MICRONEEDLE PATCH | Jul 19, 2021 | Pending |
Array
(
[id] => 18597683
[patent_doc_number] => 20230272480
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-31
[patent_title] => Methods for Classifying Cancer
[patent_app_type] => utility
[patent_app_number] => 18/015989
[patent_app_country] => US
[patent_app_date] => 2021-07-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12613
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 100
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18015989
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/015989 | Methods for Classifying Cancer | Jul 14, 2021 | Pending |
Array
(
[id] => 17370383
[patent_doc_number] => 20220025435
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-27
[patent_title] => METHODS AND SYSTEMS FOR ENRICHMENT OF BARCODES
[patent_app_type] => utility
[patent_app_number] => 17/366248
[patent_app_country] => US
[patent_app_date] => 2021-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31814
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17366248
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/366248 | METHODS AND SYSTEMS FOR ENRICHMENT OF BARCODES | Jul 1, 2021 | Abandoned |
Array
(
[id] => 18612766
[patent_doc_number] => 20230279502
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-07
[patent_title] => IDENTIFICATION OF ESTROGEN RECEPTOR POSITIVE (ER+) BREAST CANCERS THAT WILL NOT DEVELOP TAMOXIFEN RESISTANCE
[patent_app_type] => utility
[patent_app_number] => 18/013368
[patent_app_country] => US
[patent_app_date] => 2021-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26283
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 190
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18013368
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/013368 | IDENTIFICATION OF ESTROGEN RECEPTOR POSITIVE (ER+) BREAST CANCERS THAT WILL NOT DEVELOP TAMOXIFEN RESISTANCE | Jun 28, 2021 | Pending |
Array
(
[id] => 18537892
[patent_doc_number] => 20230242995
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-03
[patent_title] => METHOD FOR DETECTING COLORECTAL CANCER
[patent_app_type] => utility
[patent_app_number] => 18/013178
[patent_app_country] => US
[patent_app_date] => 2021-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11431
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18013178
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/013178 | METHOD FOR DETECTING COLORECTAL CANCER | Jun 28, 2021 | Pending |
Array
(
[id] => 17185538
[patent_doc_number] => 20210332423
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-28
[patent_title] => HIGHLY STABLE AND SPECIFIC MOLECULAR BEACONS ENCAPSULATED IN CATIONIC LIPOPLEX NANOPARTICLES AND APPLICATION THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/357862
[patent_app_country] => US
[patent_app_date] => 2021-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7928
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 121
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17357862
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/357862 | Highly stable and specific molecular beacons encapsulated in cationic lipoplex nanoparticles and application thereof | Jun 23, 2021 | Issued |
Array
(
[id] => 18538709
[patent_doc_number] => 20230243813
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-03
[patent_title] => METHODS FOR SELECTING AND TREATING CANCER WITH FGFR3 INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 18/002076
[patent_app_country] => US
[patent_app_date] => 2021-06-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 52783
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -90
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18002076
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/002076 | METHODS FOR SELECTING AND TREATING CANCER WITH FGFR3 INHIBITORS | Jun 21, 2021 | Pending |